February 24, 2025 - 17:05

MOBILE, Ala. — Saad Healthcare, operating in Mobile and Baldwin counties, has reached a significant settlement of $3 million following allegations of violating the False Claims Act. The settlement stems from claims that the healthcare group engaged in improper billing practices, which ultimately led to inflated charges to federal healthcare programs.
The allegations suggest that Saad Healthcare submitted false claims for services that were either not provided or not medically necessary. This settlement highlights ongoing concerns regarding compliance within the healthcare sector and the importance of adhering to regulations designed to protect patients and taxpayers alike.
As part of the agreement, Saad Healthcare has committed to implement enhanced compliance measures to prevent future violations. The settlement reflects a broader effort by authorities to hold healthcare providers accountable and ensure that federal funds are utilized appropriately. The case serves as a reminder of the critical need for transparency and ethical practices in the healthcare industry.
 
                November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
 
                October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
 
                October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
 
                October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...